Evidence map›Paper›PMID 23817427›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

A protective Hsp70-TLR4 pathway in lethal oxidant lung injury.

Yi Zhang, Xuchen Zhang, Peiying Shan, Clayton R Hunt, Tej K Pandita, Patty J Lee

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. NADPH Oxidase 3: Beyond the Inner Ear.Antioxidants (Basel, Switzerland) · 2024
    Review
  4. Bioengineered nanotechnology for nucleic acid delivery.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. TLR4 is required for macrophage efferocytosis during resolution of ventilator-induced lung injury.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Exosomes mediate sensory hair cell protection in the inner ear.The Journal of clinical investigation · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Oxidative stress diseases unique to the perinatal period: A window into the developing innate immune response.American journal of reproductive immunology (New York, N.Y. : 1989) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yi ZhangSection of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Xuchen Zhang
Peiying Shan
Clayton R Hunt
Tej K Pandita
Patty J Lee
Yale University · USThe University of Texas Southwestern Medical Center · US

Funding

Heme Oxygenase-1 in Lung Ischemia-Reperfusion InjuryR01HL071595 · NHLBI · YALE UNIVERSITY · PI LEE, PATTY J · 2004 to 2012
$3.4M
CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITYR01CA129537 · NCI · WASHINGTON UNIVERSITY · PI PANDITA, TEJ K · 2008 to 2018
$3.3M
Innate Immune Mechanisms in EmphysemaR01HL090660 · NHLBI · YALE UNIVERSITY · PI LEE, PATTY J · 2009 to 2012
$1.7M
Tumor-cell-specific targets for combined hyperthermia and radiation effectsR01CA154320 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI PANDITA, TEJ K · 2010 to 2014
$1.6M
NCI NIH HHS R01 CA129537NCI NIH HHS R01CA129537NCI NIH HHS R01 CA154320NCI NIH HHS R01CA154320NHLBI NIH HHS HL 071595NHLBI NIH HHS HL 090660NHLBI NIH HHS R01 HL071595NHLBI NIH HHS R01 HL090660
6 · The paper itself

Abstract

Administering high levels of inspired oxygen, or hyperoxia, is commonly used as a life-sustaining measure in critically ill patients. However, prolonged exposures can exacerbate respiratory failure. Our previous study showed that TLR4 confers protection against hyperoxia-induced lung injury and mortality. Hsp70 has potent cytoprotective properties and has been described as a TLR4 ligand in cell lines. We sought to elucidate the relationship between TLR4 and Hsp70 in hyperoxia-induced lung injury in vitro and in vivo and to define the signaling mechanisms involved. Wild-type, TLR4(-/-), and Trif(-/-) (a TLR4 adapter protein) murine lung endothelial cells (MLECs) were exposed to hyperoxia. We found markedly elevated levels of intracellular and secreted Hsp70 from wild-type mice lungs and MLECs after hyperoxia. We confirmed that Hsp70 and TLR4 coimmunoprecipitate in lung tissue and MLECs. Hsp70-mediated NF-κB activation appears to depend upon TLR4. In the absence of TLR4, Hsp70 loses its protective effects in endothelial cells. Furthermore, these protective properties of Hsp70 are TLR4 adapter Trif dependent and MyD88 independent. Hsp70-deficient mice have increased mortality during hyperoxia, and lung-targeted adenoviral delivery of Hsp70 effectively rescues both Hsp70-deficient and wild-type mice. To our knowledge, our studies are the first to define an Hsp70-TLR4-Trif cytoprotective axis in the lung and endothelial cells. This pathway is a potential therapeutic target against a range of oxidant-induced lung injuries.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsEndothelial CellsEnzyme ActivationHSP70 Heat-Shock ProteinsHyperoxiaLungLung InjuryMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88NF-kappa BOxygenRNA, MessengerSignal TransductionAdaptor Proteins, Vesicular TransportHSP70 Heat-Shock ProteinsMyd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BOxygenRNA, MessengerTicam1 protein, mouseTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID23817427
PMCPMC3730854
OpenAlexW2161297853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.